Precedence Research

Red Biotechnology Market (By Product Type: Gene Recombinant Drugs, Human Vaccines, Blood Products Diagnostics Reagents Personalized Medicines, Others; By Application: Pharmacogenomics, Gene Therapy, Genetic Testing and Biopharmaceutical Production; By End-User: Research Institutes, CMOs & CROs, Biopharmaceutical Industries, Others) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024 - 2033
The global red biotechnology market size was valued at USD 385.01 billion in 2023 and is expected to reach over USD 649.31 billion by 2033, growing at a compound annual growth rate (CAGR) of around 5.36% during the forecast period 2024 to 2033. 
Asthma Drugs Market (By Medication: Quick Relief Medications, Long-term Control Medications, Others; By Mode of Administration: Tablets and Capsules, Liquids, Inhalers, Injections, and Sprays and Powders; By Organization Type: Public, Private; By Application: Pediatric, Adults, Adolescent) - Global Market Size, Share, Growth, Trends Analysis, Regional Outlook and Forecasts 2024 - 2033
The global asthma drugs market was estimated at USD 23.93 billion in 2023 and is predicted to reach over USD 39.35 billion by 2033, growing at a CAGR of 5.09% during the forecast period 2024 to 2033.
U.S. Over the Counter (OTC) Drugs Market (By Product Type: Vitamin and Dietary Supplements, Cough and Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Botanicals, Antacids, Smoking Cessation Products, Feminine Care, Others; By Dosage Form; By Route of Administration; By Distribution Channel) - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033
The U.S. over the counter (OTC) drugs market size was estimated at USD 23.03 billion in 2023 and is projected to hit around USD 41.72 billion by 2033, growing at a CAGR of 6.42% from 2024 to 2033.
Fertility Market (By Offering: Assisted Reproductive Technology (IVF, Artificial Insemination, Surrogacy, and Others), Fertility Drugs (Gonadotropin, Anti-estrogen, and Others), Others; By End user: Fertility Clinics, Hospitals, and Clinical Research Institutes) - Global Industry Analysis, Market Size, Share, Growth, Trends, Regional Outlook And Forecasts, 2021 - 2027
The global fertility market was valued at USD 26.88 billion in 2020 and projected to reach USD 45.40 billion by 2027, at a noteworthy CAGR of 4.7% during the forecast period 2021 to 2027.
Generic Drugs Market (Drug Type: Simple Generics and Super Generics; By Brand: Pure generic drugs and Branded generic drugs; By Route of Drug Administration: Oral, Injection, Cutaneous, Others; By Therapeutic Application: Central Nervous System (CNS), Cardiovascular, Infectious Diseases, Musculoskeletal Diseases, Respiratory, Oncology, Others; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global generic drugs market size was valued at USD 464.98 billion in 2023 and is projected to hit around USD 776.78 billion by 2033, growing at a CAGR of 5.2% over the forecast period from 2024 to 2033.
Conjunctivitis Market (By Type: Bacterial Conjunctivitis, Viral Conjunctivitis, and Allergic Conjunctivitis; By Patients Type: Pediatric and Adults; By Drug Class: Antibiotics, Anti-Histaminic, Decongestant, Steroid Drugs, and Others) - Global Market Size, Share, Growth, Trends Analysis, Regional Outlook and Forecasts 2023 - 2032
The global conjunctivitis market size was estimated at USD 4.80 billion in 2022 and is predicted to surpass around USD 8.08 billion by 2032, expanding immensive CAGR of 5.40% during the estimate period 2023 to 2032. 
Cancer/Oncology Drugs Market (By Drug Class: Targeted Therapy, Chemotherapy, Hormonal Therapy, and Immunotherapy; By Indication: Lungs Cancer, Colorectal Cancer, Melanoma, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023–2032
The oncology/cancer drugs market size was valued at USD 138.41 billion in 2022 and is projected to hit around USD 401.31 billion by 2032, growing at a CAGR of 11.43% from 2023 to 2032.
Over the Counter (OTC) Drugs Market (By Product Type: Analgesics, Cold & Cough Remedies, Digestives & Intestinal Remedies, Skin Treatment, Vitamins & Minerals, Others; By Distribution Channel: Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033
The global over the counter (OTC) drugs market size was valued at USD 125.28 billion in 2023 and is expected to reach over USD 229.01 billion by 2033, expanding growth at a registered CAGR of 6.51% from 2024 to 2033.
Immunotherapy Drugs Market (By Drug Type: Monoclonal Antibodies, Vaccines, Interleukins, Interferons Alpha & Beta, Others; By Therapeutic Area: Cancer, Infectious Diseases, Autoimmune & Inflammatory Diseases, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global immunotherapy drugs market size was valued at USD 202.64 billion in 2022 and is expected to hit around USD 1,013 billion by 2032 with a CAGR of 18% from 2023 to 2032.
Head and Neck Cancer Drugs Market (By Treatment Type: Chemotherapy, Radiation Therapy, Targeted Therapy, and Immunotherapy; By Sales Channel: Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030
The global head and neck cancer drugs market size was valued at US$ 1.51 billion in 2021 and is expected to reach over US$ 2.99 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2030.
Asthma and COPD Drugs Market (By Diseases: Asthma, COPD; By Medication Class: Combination Drugs, Bronchodilators, Inhaled Corticosteroids (ICS), Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics, Anti-Inflammatories, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global asthma and COPD drugs market size was estimated at US$ 36 billion in 2022 and is expected to hit US$ 58.92 billion by 2032 with a registered CAGR of 5.10% from 2023 to 2032.
Contraceptive Drugs Market (By Product: Oral, Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal Implants, Injectable, Others: By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs, Others: By Age Group: 15–24 years, 25–34 years, 35–44 years, Above 44 years)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global contraceptive drugs market size was valued at USD 16.83 billion in 2023 and it is expected to hit around US$ 27.72 billion by 2032, poised to grow at a CAGR of 5.70% from 2023 to 2032.
Rheumatoid Arthritis Drugs Market (By Molecule: Pharmaceuticals, Biopharmaceuticals; By Sales Channel: Prescription, Over-the-Counter (OTC); By Route of Administration: Oral, Parenteral) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global rheumatoid arthritis drugs market size was estimated at US$ 61 billion in 2022 and it is expected to hit US$ 71.14 billion by 2032 with a registered CAGR of 1.60% from 2023 to 2032.
Cardiovascular Drugs Market (By Drug Type: Antihypertensive, Anticoagulants, Antihyperlipidemic, Antiplatelet Drugs, Others; By Disease Indication: Hypertension, Coronary Artery Disease, Hyperlipidaemia, Arrhythmia, Others; By Route of Administration: Oral, Parenteral, Others; By Drug Classification; By Mode of Purchase; By End Users) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global cardiovascular drugs market size was valued at USD 138.33 billion in 2022 and is expected to reach around USD 200.9 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 3.8% between 2023 and 2032.
Antipsychotic Drugs Market (By Therapeutic Class: First Generation, Second Generation, Third Generation; By Disease: schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases; By Drug: Risperidone, Quetiapine, Olanzapine, Aripiprazole, Others; By Distribution Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global antipsychotic drugs market size was valued at USD 17.43 billion in 2023 and is anticipated to reach around USD 31.37 billion by 2033, growing at a CAGR of 6.05% from 2024 to 2033.
Orphan Drugs Market (By Drug Type: Biologicals, Non-Biologicals; By Therapy: Oncology, Haematology, Neurology, Infectious Diseases, Metabolic Disorders, Endocrinology, Immunology, Others; By distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global orphan drugs market size accounted for USD 154 billion in 2022 and is projected to hit around USD 484.73 billion by 2032, expanding at a notable compound annual growth rate (CAGR) of 12.2% during the forecast period from 2023 to 2032. 
Dermatology Drugs Market (By Indication: Acne, Psoriasis, Rosacea, Alopecia, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Administration Analysis: Topical Administration, Oral Administration, Parenteral Administration) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global dermatology drugs market size accounted for USD 19.22 billion in 2023 and is projected to hit around USD 56.27 billion by 2033, growing at a CAGR of 11.32% during the forecast period 2024 to 2033.
Veterinary Dermatology Drugs Market (By Animal Type: Companion Animal, Livestock Animal; By Route of Administration: Oral, Topical, Injectable; By Indication: Parasitic Infections, Allergic Infections, Others; By Distribution Channel: Retail, E-Commerce, Hospital Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global veterinary dermatology drugs market size was exhibited at USD 6.88 billion in 2022 and is projected to hit around USD 16.51 billion by 2032 with a registered CAGR of 9.2% during the forecast period 2023 to 2032. Drugs for veterinary dermatology are used t
Ophthalmic Drugs Market (By Disease: Eye Allergy, Eye Infection, Glaucoma, Retinal disorders, Dry Eye, Others; By Drug Class: Anti-Allergy, Anti-Inflammatory, Antiglaucoma, Anti-VEGF Agents; By Dosage: Eye Solutions, Gels, Capsules, Eye Drops, Ointments; By Administration: Systematic, Topical Local Ocular; By Product: Prescription Drugs, Over-the-Counter-Drugs) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2033
The global ophthalmic drugs market size was estimated at USD 41.17 billion in 2023 and is projected to hit around USD 68.90 billion by 2033, growing at a CAGR of 5.33% during the forecast period from 2024 to 2033.
US Generic Drugs Market (By Drug Type: Simple Generics, Super Generics; By Brand: Pure Generic Drugs, Branded Generic Drugs; By Route of Administration: Oral, Injection, Cutaneous, Others; By Distribution Channels; By Therapeutic Application) - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2033
The US generic drugs market size was evaluated at USD 133.44 billion in 2023 and is projected to hit around USD 189.77 billion by 2033, registering a CAGR of 3.5% from 2024 to 2033.
Pain Management Drugs Market (By Drug Class: NSAIDs, Opioids, Anesthetics, Antidepressants, Anticonvulsants, Others; By Indication: Arthritic Pain, Neuropathic Pain, Chronic Back Pain, Post-Operative Pain, Cancer Pain, Others; By Distribution Channel: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global pain management drugs market size was estimated at USD 78.41 billion in 2022 and is projected to hit around USD 115.50 billion by 2032, growing at a CAGR of 4% during the forecast period 2023 to 2032.
Intravenous Iron Drugs Market (By Product: Iron Sucrose, Iron Dextran, Ferric Carboxymaltose; By Application: Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Other Disease) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global intravenous iron drugs market size was valued at USD 3.24 billion in 2023 and is anticipated to reach around USD 7.41 billion by 2033, growing at a CAGR of 8.62% from 2024 to 2033. Intravenous iron medications provide a number of benefits over oral iron supplements, including quicker and more effective iron replenishment, particularly
Nephrology Drugs Market (By Drug Class: ACE Inhibitors, Angiotensin Receptor Blockers, B-Blockers, Calcium Channel Blockers, Loop Diuretics, Erythropoiesis-Stimulating Agents, Phosphate Binders, Others; By Route of Administration: Oral, Subcutaneous, Intravenous; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global nephrology drugs market size was estimated at USD 15.9 billion in 2022 and it is expected to hit around USD 27.2 billion by 2032, growing at a CAGR of 5.52% from 2023 to 2032.
Antifungal Drugs Market (By Drug Class: Echinocandins, Azoles, Allylamines, Polyenes, Others; By Indication: Aspergillosis, Dermatophytosis, Candidiasis, Others; By Infection Type: Systemic Antifungal Infections, Superficial Antifungal Infections) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global antifungal drugs market size was exhibited at USD 16.81 billion in 2023 and is projected to hit around USD 22.88 billion by 2032, growing at a CAGR of 3.49% between 2023 and 2032.
Cancer Supportive Care Drugs Market (By Therapeutic Class: ESA, G-CSFs, Antiemetics, Bisphosphonates, Opioids, NSAIDs; By Application: Breast Cancer, Stomach Cancer Colorectal Cancer, Liver Cancer, Prostate Cancer; By Distribution Channel: Drug pharmacies/ Retail pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global cancer supportive care drugs market size was reached at USD 20.96 billion in 2022 and it is projected to hit around USD 25.78 billion by 2032, growing at a CAGR of 2.09% during the forecast period from 2023 and 2032. The rising awareness about adverse effects caused by prolonged cancer treatment is expected to boost t
Atopic Dermatitis Drugs Market (By Drug Class: Biologics, Calcineurin Inhibitors, PDE-4 Inhibitor, Corticosteroids, Others; By Route Of Administration: Topical, Injectable, Oral; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global atopic dermatitis drugs market size was estimated at USD 12.6 billion in 2022 and is predicted to reach around USD 27.33 billion by 2032, registering a CAGR of 8.1% during the forecast period from 2023 to 2032.
Hyperlipidemia Drugs Market (By Drug Class: Statins Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Combination, Miscellaneous; By Route of Administration: Oral, Parenteral, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global hyperlipidemia drugs market size was estimated at USD 21.2 billion in 2022 and is projected to hit around USD 31.23 billion by 2032, registering a CAGR of 4% from 2023 to 2032.
Pediatric Drugs Market (By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs; By Route of Administration: Oral, Topical, Parenteral, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global pediatric drugs market size was estimated at USD 115.6 billion in 2022 and is projected to hit around USD 363.86 billion by 2032, registering a CAGR of 12.2% from 2023 to 2032.
Inhalable Drugs Market (By Drug Class: Aerosol, Dry powder formulation, Spray; By Application: Respiratory diseases, Non-respiratory disease) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global inhalable drugs market size reached USD 33.31 billion in 2023 and is projected to hit around USD 58.21 billion by 2032, expanding at a CAGR of 6.40% during the forecast period from 2023 to 2032.
Genitourinary Drugs Market (By Indication: Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence & Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Haematuria, Benign Prostatic Hyperplasia; By Product: Urologicals, Hormonal Therapy, Gynecological, Anti-infectives, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global genitourinary drugs market size was exhibited at USD 29.24 billion in 2023 and is projected to be worth around USD 32.27 billion by 2032, growing at a CAGR of 1.1% during the forecast period from 2023 to 2032.
© Copyright 2024, All rights reserved. Precedence Research Pvt. Ltd.